Lactulose is a synthetic disaccharide used as a laxative and treatment for hepatic encephalopathy. It works by drawing water into the colon, softening the stool and accelerating bowel movements. It is used for relief of occasional constipation and treatment of hepatic encephalopathy. Lactulose is derived from lactose, a sugar found naturally in milk and milk products and thus provides a natural laxation effect without causing dependence on the body. With rising cases of constipation and adoption of preventive healthcare, the demand for lactulose as a natural laxative has increased significantly.
The Global Lactulose Market Size is estimated to be valued at US$ 201.94 Bn in 2024 and is expected to exhibit a CAGR of 13. % over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the lactulose market are Amgen Inc., F. Hoffmann-La Roche AG., Intas Pharmaceuticals Ltd., AstraZeneca plc, Mylan N.V., Dr. Reddy's Laboratories, Bristol - Myers Squibb, Merck & Co., Inc., BIOCAD-Biotechnology company, Reliance Life Sciences, Biocon Limited, and Hetero Drugs Limited.
Key players operating in the lactulose market are focusing on expanding their product portfolios as well as geographic footprints through mergers and acquisitions. For instance, in 2020, Mylan N.V. acquired the rights to biosimilar erythropoietin from Biocon Limited to commercialize it in the U.S. and Canada.
The demand for lactulose is increasingly rapidly due to rising prevalence of constipation worldwide. As per analyses, constipation affects approximately 16% of the global population. Growing awareness regarding available treatment options and preventive healthcare is driving the demand.
Technological advancements are expected to further fuel the growth of the lactulose market. Key players are focusing on development of lactulose products with improved taste and ease of administration to enhance patient compliance. For example, some products are available in powder form to be mixed with food or water for better palatability.
Market Trends
- Use of prebiotics: There is an increasing focus on development of lactulose products containing prebiotics such as inulin and psyllium husk. The addition of prebiotics enhances the natural laxation effect of lactulose.
- Combination therapies: Players are focusing on development of combination therapies using lactulose with other agents for synergistic treatment of constipation and hepatic encephalopathy. Some examples include lactulose with polyethylene glycol and lactitol.
Market Opportunities
- Emerging markets: Markets in Asia Pacific and Latin America offer significant untapped potential for lactulose owing to growing health awareness and rising disposable incomes in these regions.
- Online sales: Key players can leverage the e-commerce platforms to boost access and awareness about lactulose products especially in rural and remote locations. Online channels ensure convenient doorstep delivery and expand the customer reach.
Impact of COVID-19 on Lactulose market growth
The COVID-19 pandemic impacted the lactulose market significantly. During the initial outbreak and lockdowns imposed worldwide, the demand from the healthcare sector reduced drastically as non-essential medical services and elective surgeries were postponed. This adversely affected the lactulose market. However, as COVID-19 causes gastrointestinal issues like diarrhea in many patients, the demand for lactulose gradually rose from the second half of 2020. Manufacturers faced disruptions in the supply chain and faced difficulties in procuring raw materials. This resulted in a supply-demand gap. With resumption of operations and new protocols, the market is regaining lost growth momentum. However, constant variant threats and uncertainties continue to pose challenges. Emphasis on healthcare spending is expected to boost the consumption of lactulose in the coming years.
Geographical regions concentrated in terms of Lactulose market value
North America region dominates the global lactulose market in terms of value. The USA accounts for the major share due to a well-established healthcare system and rising prevalence of constipation disorders. Easy availability of advanced treatments and growing health awareness are other factors fueling the regional market. Europe holds the second largest share with major markets being Germany, UK and Italy and increasing focus on digestive care. The Asia Pacific region is projected to grow at the fastest pace during the forecast period. Improving access to healthcare, rising living standards and burgeoning medical tourism industry in China, India are supporting the regional lactulose market growth.
Fastest growing region for Lactulose market
The Asia Pacific region is expected to witness the highest growth in the global lactulose market during the forecast period. Factors such as rapidly growing economies, increasing healthcare spending, rising prevalence of lifestyle diseases like constipation and changing diets are driving the lactulose consumption in the region.China and India represent major lactulose market opportunities with large patient pools and improving access to medications. Favorable initiatives by governments towards enhancing healthcare infrastructure is further boosting the regional industry. Growing medical tourism and emergence of many local pharmaceutical players are expanding the availability of lactulose formulations. Rising health awareness is influencing greater adoption of preventive care and digestive health management. The APAC lactulose market is projected to expand at a CAGR of 16% until 2031.
Get More Insights On This Topic: Lactulose Market
